The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
May. 15, 2018

Filed:

Sep. 28, 2015
Applicant:

Kowa Company, Ltd., Nagoya-shi, Aichi, JP;

Inventors:

Yuta Inokuchi, Higashimurayama, JP;

Haruki Shibata, Higashimurayama, JP;

Toshiaki Takizawa, Higashimurayama, JP;

Assignee:

KOWA COMPANY, LTD., Nagoya-shi, JP;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/423 (2006.01); A61K 31/4152 (2006.01); A61K 45/06 (2006.01); A61K 45/00 (2006.01);
U.S. Cl.
CPC ...
A61K 31/423 (2013.01); A61K 31/4152 (2013.01); A61K 45/06 (2013.01); A61K 45/00 (2013.01); A61K 2300/00 (2013.01);
Abstract

This invention provides a combination-drug composition and a combination use of pharmaceuticals for preventing and/or treating dyslipidemic conditions such as hyper-LDL cholesterolemia in mammals, including humans. This invention pertains to a drug composition for preventing and/or treating dyslipidemia and the like, the drug composition including the following: (R)-2-[3-[[N-(benzoxazol-2-yl)-N-3-(4-methoxyphenoxy)propyl]aminomethyl]phenoxy] butyric acid, a salt thereof, or a solvate of either; and (S)-trans-{4-[({2-[({1-[3,5-bis(trifluoromethyl)phenyl]ethyl}{5-[2-(methyl sulfonyl)ethoxy]pyrimidin-2-yl}amino)methyl]-4-(trifluoromethyl)phenyl}(ethyl)amino)methyl]cyclohexyl} acetic acid, a salt thereof, or a solvate of either.


Find Patent Forward Citations

Loading…